Microparticulate based topical delivery system of clobetasol propionate

AAPS PharmSciTech

Volumn 12, Issue 3, 2011, Pages 949-957

  Badıllı, Ulya ^a   Şen, Tangül ^a   Tarımcı, Nilüfer ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

clobetasol propionate; emulgel; emulsion solvent evaporation method; poly(D,L lactic co glycolic acid) microparticles; psoriasis

Indexed keywords

CLOBETASOL PROPIONATE; MICROSPHERE; OIL; POLYGLACTIN;

ARTICLE; CREAM; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; EMULSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PSORIASIS;

EID: 80052588682     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-011-9661-7     Document Type: Article

References (42)

1. MJ Bhosle A Kulkarni SR Feldman R Balkrishnan 2006 Quality of life in patients with psoriasis Health and Quality of Life Outcomes 4 35 16756666 10.1186/1477-7525-4-35 (Pubitemid 44070282)
2. JW Fluhr C Cavallotti E Berardesca 2008 Emollients, moisturizers and keratolytic agents in psoriasis Clin Dermatol 26 380 386 18691519 10.1016/j.clindermatol.2008.01.015
3. M Lebwohl PT Ting JYM Koo 2005 Psoriasis treatment: traditional therapy Ann Rheum Dis 64 Suppl II ii83 ii86 15708945 10.1136/ard.2004.030791 1:CAS:528:DC%2BD2MXisVOrtbs%3D (Pubitemid 40288530)
4. PCM Van de Kerkhof 2005 The topical treatment of psoriasis Clin Exp Dermatol 30 205 208 15725262 10.1111/j.1365-2230.2005.01719.x (Pubitemid 40380111)
5. J Austad JR Bjerke BT Gjertsen S Helland JK Livden T Morken, et al. 1998 Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis JEADV 11 19 24 9731961 1:STN:280: DyaK1cvgtVOisg%3D%3D (Pubitemid 28383610)
6. J-C Tsai C-L Cheng Y-F Tsai H-M Sheu C-H Chou 2004 Evaluation of in vivo bioequivalence methodology for topical clobetasol 17-propionate based on pharmacodynamic modeling using chinese skin J Pharm Sci 93 1 207 217 14648650 10.1002/jps.10536 1:CAS:528:DC%2BD2cXjvFWnug%3D%3D (Pubitemid 38081828)
7. J-Y Fang C-L Fang KC Sung H-Y Chen 1999 Effect of low frequency ultrasound on the in vitro percutaneous absorption of clobetasol 17-propionate Int J Pharm 191 33 42 10556738 10.1016/S0378-5173(99)00230-6 1:CAS:528:DyaK1MXotVGjs7Y%3D (Pubitemid 29502175)
8. FQ Hu H Yuan HH Zhang M Fang 2002 Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization Int J Pharm 239 121 128 12052697 10.1016/S0378-5173(02)00081-9 1:CAS:528:DC%2BD38XktFektrY%3D (Pubitemid 34615801)
9. G Campisi G Giandalia V De Caro C Di Liberto P ArIcò LI Giannola 2004 A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A phase IV, randomized, observer-blinded, parallel group clinical trial Br J Dermatol 150 984 990 15149513 10.1111/j.1365-2133.2004. 05943.x 1:CAS:528:DC%2BD2cXlt1Kgu7s%3D (Pubitemid 38903533)
10. F-Q Hu S-P Jiang Y-Z Du H Yuan Y-Q Ye S Zeng 2006 Preparation and characteristics of monostearin nanostructured lipid carriers Int J Pharm 314 83 89 16563671 10.1016/j.ijpharm.2006.01.040 1:CAS:528:DC%2BD28XjslyjsLw%3D
11. T Şenyiǧit F Sonvico S Barbieri Ö Özer P Santi P Colombo 2010 Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin J Cont Rel 142 368 373 10.1016/j.jconrel.2009.11. 013
12. E Ga De Jalón MJ Blanco-Prieto P Ygartua S Santoyo 2001 PLGA microparticles: possible vehicles for topical drug delivery Int J Pharm 226 181 184 10.1016/S0378-5173(01)00811-0 (Pubitemid 32800792)
13. A Haddadi ES Farboud M Erfan R Aboofazeli 2006 Preparation and characterization of biodegradable urea-loaded microparticles as an approach for transdermal delivery J Microencapsulation 23 6 698 712 17118885 10.1080/02652040600789328 1:CAS:528:DC%2BD28XhtlWkt7fL (Pubitemid 44803861)
14. RA Jain 2000 The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices Biomaterials 21 2475 2490 11055295 10.1016/S0142-9612(00)00115-0 1:CAS:528:DC%2BD3cXmslKmtL0%3D
15. J Wang CW Ng KY Win P Shoemakers TKY Lee SS Feng, et al. 2003 Release of paclitaxel from polylactide-co-glycolide (PLGA) microparticles and discs under irradiation J Microencapsulation 20 3 317 327 12881113 1:CAS:528: DC%2BD3sXkvFCqsLw%3D (Pubitemid 36621474)
16. Y ÇIrpanlI N Ünlü S ÇalIş AA HIncal 2005 Formulation and in vitro characterization of retinoic acid loaded poly (lactic-co-glycolic acid) microspheres J Microencapsulation 22 8 877 889 16423759 10.1080/02652040500273878 (Pubitemid 43158189)
17. Y SamatlI N Yüksel N TarImcI 2006 Preparation and characterization of poly(D, L-lactic-co-glycolic acid) microspheres containing flurbiprofen sodium Drug Delivery 13 105 111 10.1080/10717540500313331 (Pubitemid 43162306)
18. KG Janoria AK Mitra 2007 Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres Int J Pharm 338 133 141 17363204 10.1016/j.ijpharm.2007.01.038 1:CAS:528:DC%2BD2sXlslWhtLo%3D (Pubitemid 46777228)
19. E Ga De Jalón MJ Blanco-Prieto P Ygartua S Santoyo 2001 Topical application of acyclovir loaded microparticles: quantification of the drug in porcine skin layers J Cont Rel 75 191 197 10.1016/S0168-3659(01)00395-9 (Pubitemid 32635209)
20. S Santoyo E Ga De Jalón P Ygartua MJ Renedo MJ Blanco-Prieto 2002 Optimization of topical cidofovir penetration using microparticles Int J Pharm 242 107 113 12176232 10.1016/S0378-5173(02)00178-3 1:CAS:528: DC%2BD38Xmt1ygu78%3D
21. A Sánchez JL Vila-Jato MJ Alonso 1993 Development of biodegradable microspheres and nanospheres for the controlled release of cyclosporin A Int J Pharm 99 263 273 10.1016/0378-5173(93)90369-Q (Pubitemid 23312043)
22. R Ghaderi C Sturesson J Carlfors 1996 Effect of preparative parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres made by the double emulsion method Int J Pharm 141 205 216 10.1016/0378-5173(96)04639-X 1:CAS:528:DyaK28XlvFGiurc%3D (Pubitemid 26302926)
23. S Sehra AS Dhake 2005 Formulation and evaluation of sustained release microspheres of poly-lactide-co-glycolide containing tamoxifen citrate J Microencapsulation 22 5 521 528 16361195 10.1080/02652040500162170 1:CAS:528:DC%2BD2MXhtlWmur%2FO (Pubitemid 43123890)
24. H Zhang S Gao 2007 Temozolomide/PLGA microparticles and antitumor activity against glioma C6 cancer cells in vitro Int J Pharm 329 122 128 17000068 10.1016/j.ijpharm.2006.08.027 1:CAS:528:DC%2BD28XhtlCmtLvJ (Pubitemid 44937534)
25. F Gabor B Ertl M Wirth R Mallinger 1999 Ketoprofen- poly(D, L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics J Microencapsulation 16 1 1 12 9972498 10.1080/026520499289266 1:CAS:528:DyaK1MXovF2jsw%3D%3D (Pubitemid 29045847)
26. S Mao J Xu C Cai O Germershaus A Schaper T Kissel 2007 Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres Int J Pharm 334 137 148 17196348 10.1016/j.ijpharm.2006.10.036 1:CAS:528:DC%2BD2sXjtVantr8%3D (Pubitemid 46400322)
27. S Freitas HP Merkle B Gander 2005 Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology J Cont Rel. 102 313 332 10.1016/j.jconrel.2004. 10.015 1:CAS:528:DC%2BD2MXktVCrtg%3D%3D
28. Y-Y Yang T-S Chung NP Ng 2001 Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method Biomaterials 22 231 241 11197498 10.1016/S0142-9612(00)00178-2 1:CAS:528: DC%2BD3cXotlCgurY%3D
29. EJAM Schlicher NS Postma J Zuidema H Talsma WE Hennink 1997 Preparation and characterization of poly(D, L-lactic-co-glycolic acid) microspheres containing desferrioxamine Int J Pharm 153 235 245 10.1016/S0378-5173(97)00116-6 1:CAS:528:DyaK2sXlt1Ojsrg%3D (Pubitemid 27308667)
30. B ArIca HS Kaş MN Orman AA HIncal 2002 Biodegredable bromocryptine mesylate microspheres prepared by a solvent evaporation technique. I: evaluation of formulation variables on microspheres characteristics for brain delivery J Microencapsulation 19 4 473 484 12396384 10.1080/02652040210144216
31. HS Choi S-A Seo G Khang JM Rhee HB Lee 2002 Preparation and characterization of fentanyl-loaded PLGA microspheres: in vitro release profiles Int J Pharm 234 195 203 11839450 10.1016/S0378-5173(01)00968-1 1:CAS:528:DC%2BD38XhtFKjsr4%3D (Pubitemid 34142624)
32. HG Jagadeesh VK Devi 2010 Tamoxifen loaded poly (ε-caprolactone) based injectable microspheres for breast cancer Int J Pharm Pharmaceut Sci 2 4 189 195
33. A Fernandez-Carballido R Herrero-Vanrell IT Molina-Martinez P Pastoriza 2004 Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration: effect of labrafil addition on release in vitro Int J Pharm 279 33 41 15234792 10.1016/j.ijpharm.2004.04.003 1:CAS:528:DC%2BD2cXltlygurk%3D (Pubitemid 38968640)
34. HS Mahajan SG Gattani 2009 Gellan gum based microparticles of metoclopromide hydrochloride for intranasal delivery: development and evaluation Chem Pharm Bull 57 4 388 392 19336933 10.1248/cpb.57.388 1:CAS:528: DC%2BD1MXmtl2gu7o%3D
35. NS Barakat MA Radwan 2006 In vitro performance of carbamazepine loaded to various molecular weights of poly(D, L-lactide-co-glycolide) Drug Delivery. 13 9 18 16401588 10.1080/10717540500308992 1:CAS:528:DC%2BD28Xks1Skuw%3D%3D (Pubitemid 43087615)
36. T Heya H Okada Y Ogawa H Toguchi 1991 Factors influencing the profiles of TRH release from copoly(d, l-lactic/glycolic acid) microspheres Int J Pharm 72 199 205 10.1016/0378-5173(91)90108-Z 1:CAS:528:DyaK3MXkslyrs7s%3D
37. BS Zolnik PE Leary DJ Burgess 2006 Elevated temperature accelerated release testing of PLGA microspheres J Cont Rel. 112 293 300 10.1016/j.jconrel.2006.02.015 1:CAS:528:DC%2BD28XkvVWktro%3D (Pubitemid 43737147)
38. JM Bezemer R Radersma DW Grijpma PJ Dijkstra CA Van Blitterswijk J Feijen 2000 Microspheres for protein delivery prepared from amphiphilic multiblock copolymers 2. modulation of release rate J Cont Rel 67 249 260 10.1016/S0168-3659(00)00212-1 1:CAS:528:DC%2BD3cXjsVegtr0%3D (Pubitemid 30303839)
39. X Fu Q Ping Y Gao 2005 Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres J Microencapsulation. 22 7 705 714 16421082 10.1080/02652040500162196 1:CAS:528:DC%2BD28XksF2qsw%3D%3D (Pubitemid 43158192)
40. D Klose F Siepmann K Elkharraz S Krenzlin J Siepmann 2006 How porosity and size affect the drug release mechanisms from PLGA-based microparticles Int J Pharm 314 198 206 16504431 10.1016/j.ijpharm.2005.07.031 1:CAS:528: DC%2BD28Xktlejtr8%3D
41. S Mao Y Shi L Li J Xu A Schaper T Kissel 2008 Effects of process and formulation parameters on characteristics and internal morphology of poly(D, L-lactide-co-glycolide) microspheres formed by the solvent evaporation method Eur J Pharm Biopharm 68 214 223 17651954 10.1016/j.ejpb.2007.06.008 1:CAS:528:DC%2BD1cXlsF2msw%3D%3D
42. S-Y Yen KC Sung J-J Wang OY-P Hu 2001 Controlled release of nalbuphine propionate from biodegradable microspheres: in vitro and in vivo studies Int J Pharm 220 91 99 11376971 10.1016/S0378-5173(01)00649-4 1:CAS:528: DC%2BD3MXjs1yrtLY%3D (Pubitemid 32476845)